Dr. Denise Yardley
Claim this profileSarah Cannon Research Institute
Studies Breast Cancer
Studies Head and Neck Cancers
9 reported clinical trials
21 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 positive
Stage III
2Head And Neck Cancers
Stage IV
HER2 positive
HER2 negative
Affiliated Hospitals
Clinical Trials Denise Yardley is currently running
Abemaciclib + Elacestrant
for Brain Metastasis from Breast Cancer
This trial tests a combination of two drugs, elacestrant and abemaciclib, in patients with a specific type of breast cancer. It aims to find the best dose and see how well it works for those whose cancer has spread to the brain. The drugs work by blocking signals that help cancer cells grow and divide. Abemaciclib is a drug that has been approved for the treatment of certain advanced breast cancers.
Recruiting1 award Phase 1 & 212 criteria
ARX788
for HER2-Positive Breast Cancer
This trial tests ARX788, a new IV medicine, for patients with HER2-positive metastatic breast cancer who did not respond well to T-DXd. The medicine targets a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 28 criteria
More about Denise Yardley
Clinical Trial Related2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Denise Yardley has experience with
- Trastuzumab SC
- Trastuzumab-emtansine
- Paclitaxel
- Abemaciclib
- Elacestrant
- ARX788
Breakdown of trials Denise Yardley has run
Breast Cancer
Head and Neck Cancers
Breast cancer
Limbic-predominant Age-related TDP-43 Encephalopathy
Permanent Neurological Damage
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Denise Yardley specialize in?
Denise Yardley focuses on Breast Cancer and Head and Neck Cancers. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Denise Yardley currently recruiting for clinical trials?
Yes, Denise Yardley is currently recruiting for 6 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Denise Yardley has studied deeply?
Yes, Denise Yardley has studied treatments such as Trastuzumab SC, trastuzumab-emtansine, Paclitaxel.
What is the best way to schedule an appointment with Denise Yardley?
Apply for one of the trials that Denise Yardley is conducting.
What is the office address of Denise Yardley?
The office of Denise Yardley is located at: Sarah Cannon Research Institute, Nashville, Tennessee 37203 United States. This is the address for their practice at the Sarah Cannon Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.